Pfizer CEO Joins Pharma Executives Selling Stock in Rally
- Share sales were done under prearranged trading plans
- Moderna executives have drawn scrutiny for insider stock sales
This article is for subscribers only.
Pfizer Inc. Chief Executive Officer Albert Bourla pocketed about $5.6 million after selling stock, the latest executive to reap the rewards of insider-share transactions amid a vaccine-fueled rally for some pharmaceutical companies.
Bourla disposed of more than 130,000 shares on Monday, according to a filing with the U.S. Securities and Exchange Commission. Sally Susman, executive vice president and chief corporate affairs officer at Pfizer, also offloaded about $1.8 million in stock.